title: Diagnostic and therapeutic challenges.
authors.affiliation: Department of Ophthalmology, University Clinic Hospital, Spain.
authors.forename: Francisco J
authors.initials: FJ
authors.lastname: Ascaso
authors.forename: Beatriz
authors.initials: B
authors.lastname: Jimenez
authors.forename: Miguel A
authors.initials: MA
authors.lastname: Fuertes
authors.forename: Srinivas
authors.initials: S
authors.lastname: Sadda
authors.forename: Pearse A
authors.initials: PA
authors.lastname: Keane
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis* / Q000188:drug therapy; D007958:Leukocyte Count; D008198:Lymph Nodes / Q000473:pathology; D008297:Male; D008875:Middle Aged; D019572:Retinal Neoplasms / Q000175:diagnosis* / Q000188:drug therapy; D000069283:Rituximab; D013163:Splenomegaly / Q000175:diagnosis; D014057:Tomography, X-Ray Computed; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives; D015354:Vision, Low / Q000175:diagnosis; D014792:Visual Acuity; D018630:Vitreoretinopathy, Proliferative / Q000175:diagnosis; D014823:Vitreous Hemorrhage / Q000175:diagnosis
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D003520:Cyclophosphamide; D014740:Vidarabine; C024352:fludarabine